Delivery Order SPE2DB24D8002-SPE2DB25FJNNA

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $10,506.31 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG TABLET 8S, a prescription medication. The award is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical products,...
This federal contract award, with ID SPE2DB24D8001|SPE2DB25FKZHJ, was issued by the Defense Logistics Agency (DLA) to the prime contractor Dakota Drug, Inc., a self-certified small disadvantaged business. The $1,020.34 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period through March 4, 2025. The contract is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was made by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,362.08 firm fixed-price delivery order is for the provision of NURTEC ODT 75 MG tablets. This contract falls under DLA's ECAT Generation V Program, which aims to procure commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...
This federal contract award, identified as SPE2DX15D8002|SPE2DX24F2WD5, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $7,287.36 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a performance period extending through May 3, 2024. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This federal contract award, identified as SPE2DX15D8001|SPE2DX24FBRBZ, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,946.47 firm fixed-price delivery order is for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a completion date of June 18, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a comprehensive range of pharmaceutical products, medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, valued at $2,997.26, is for the delivery of NURTEC ODT 75 MG TABLET 8S and does not have a set-aside designation. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, identified as SPE2DB24D8001 and valued at $999,999,999.00. This IDC is...
This firm fixed-price delivery order contract, valued at $14,543.54, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product NURTEC ODT 75 MG TABLET 8S, which supports the medical supply chain operations of the U.S. Armed Forces. The contract has an ultimate completion date of June 11, 2024 and was awarded on June 10, 2024 without any set-aside...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product, with a ceiling value of $12,238.31 and a period of performance through November 22, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) awarded to Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $15,803.27, is for the delivery of NURTEC ODT 75 MG TABLET 8S. This order is placed under Dakota Drug's existing Indefinite Delivery Contract (IDC) SPE2DB24D8001 with the DLA, which has a ceiling value of $999,999,999.00. The IDC allows Dakota Drug to provide a range of pharmaceutical...
This is a firm fixed-price delivery order awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $10,688.88 contract is for the supply of NURTEC ODT 75 MG TABLET 8S to the Defense Logistics Agency (DLA), which is a Defense agency. The award is associated with a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. (SPE2DB24D8001) valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V...
  • SPE2DB24D8002
    Indefinite Delivery Contract
  • SPE2DB24D8002-SPE2DB25FJNNA
    Delivery Order

This federal contract award, valued at $10,808.49, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is a Delivery Order (SPE2DB25FJNNA) for the supply of NURTEC ODT 75 MG TABLET 8S, a pharmaceutical product.

Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at $999,999,999.00. This IDC is part of the DLA Troop Support Medical's ECAT Generation V Program, which seeks proposals for commercial medical equipment, accessories, consumables, and medical simulation equipment used by medical professionals. Under this contract, Dakota Drug, Inc. can efficiently deliver critical medical items to various defense healthcare facilities, demonstrating its strategic importance in the military medical supply chain.

The contract award is not set-aside and has an ultimate completion date of April 16, 2025.

Generated 7/15/25, 4:04 PM